PREVIOUS
✖
Gennova mRNA Vaccine
July 3 , 2022
880 days
904
0
- The Gennova mRNA-based vaccine, GEMCOVAC-19, is India's first homegrown mRNA COVID- 19 vaccine.
- It is the first mRNA vaccine that remains stable during storage even at 2-8 degrees Celsius.
- While most of the other mRNA vaccines have to be stored at sub-zero temperatures.
- It has got emergency use authorization in emergency situations for all adults aged above 18 years.
- The Drugs Controller General of India (DCGI) gave its approval.
- It was developed by Pune-based Gennova Biopharmaceuticals.
- mRNA is short for messenger RNA, a type of RNA found in cells that is used for the production of proteins.
- The mRNA vaccine teaches our cells how to make a protein that will trigger an immune response inside our bodies.
- The mRNA vaccines protect us from infectious diseases by activating cells to fight against invading virus.
- The immune response leads to the creation of antibodies that are required to fight the foreign virus by targeting that particular piece of protein.
- The mRNA-based Covid-19 vaccines send instructions to the cells to create a piece of protein known as spike protein.
- It is the same as the one found studded on the surface of the novel coronavirus.
- These proteins have been engineered to stop them from replicating.
- The Pfizer-BioNTech and Moderna COVID-19 vaccines are both mRNA vaccines.
- The children are being administered Corbevax COVID-19 vaccine manufactured by Hyderabad-based Biological E.
Leave a Reply
Your Comment is awaiting moderation.